Integrating HCV and HIV Screening During the Era of HIV Antigen Testing
- Conditions
- HIVHepatitis C
- Interventions
- Behavioral: QuestionnaireProcedure: Rapid finger stickProcedure: Venipuncture
- Registration Number
- NCT02869776
- Lead Sponsor
- Boston Medical Center
- Brief Summary
The objective of this proposal is to develop an optimal testing strategy for HCV and HIV in high prevalence settings, such as detoxification centers with a large proportion of young injection drug users. The latest venipuncture testing will be compared to rapid finger stick testing for HCV and HIV. Outcomes for each strategy among individuals admitted at a short-term drug detoxification center will be determined.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
- Age greater or equal to 18
- All clients admitted to BTC with a history of drug or alcohol use
- Individuals who self-report as being HIV and HCV non-infected within the past 6 months or having unknown status
- Participants providing contact information of two family members or friends
- Individuals signing a medical records release form for the referral site (Boston Medical Center)
- English speaking
- Individuals unable to provide informed consent
- Individuals with a known history of HCV and/or HIV
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Rapid finger stick Rapid finger stick HIV and HCV testing through rapid finger stick. Behavioral questionnaires will also be administered. Standard venipuncture Venipuncture HIV and HCV testing through venipuncture. Behavioral questionnaires will also be administered. Rapid finger stick Questionnaire HIV and HCV testing through rapid finger stick. Behavioral questionnaires will also be administered. Standard venipuncture Questionnaire HIV and HCV testing through venipuncture. Behavioral questionnaires will also be administered.
- Primary Outcome Measures
Name Time Method Number of participants who receive HIV test results within 5 days (by the time of discharge from the detoxification center) The number of participants who receive HIV test results by the time they are discharged from the detoxification center
Number of participants who receive HCV test results within 5 days (by the time of discharge from the detoxification center) The number of participants who receive HCV test results by the time they are discharged from the detoxification center
- Secondary Outcome Measures
Name Time Method Number of participants who have HCV treatment initiated by six months The number participants who have HCV treatment initiated
Number of participants who link to HCV care by three months The number of participants who are seen for an HCV visit
Number of participants who have fibrosis staging performed by three months The number participants who have fibrosis staging performed
Number of participants who reach sustained virologic response by twelve months The number participants who reach sustained virologic response
Number of participants who HIV RNA testing by 3 months The number participants who have HIV RNA testing
Number of participants who achieve HIV viral suppression by 6 months The number participants who achieve HIV viral suppression
Number of participants who link to HIV care by 3 months The number participants who are seen for an HIV visit
Number of participants who have antiretroviral treatment initiated by 3 months The number participants who initiated antiretroviral treatment
Number of participants who have HCV RNA testing by three months The number of participants who have HCV RNA testing performed
Number of participants who have CD4 testing by 3 months The number participants who have CD4 testing
Trial Locations
- Locations (1)
Boston Medical Center
🇺🇸Boston, Massachusetts, United States